GSK Avoids Batch Loss with Aspen Process Pulse™ and Aspen Unscrambler™
GSK, a leading multinational pharmaceutical and biotechnology company, consistently seeks innovative solutions to develop new vaccines and specialty medicines efficiently and with top quality. In pursuit of this goal, they sought a solution to address pH variability in bioreactors, aiming to mitigate risks to product batches and reduce process drift and equipment failures.
By implementing Aspen Process Pulse and Aspen Unscrambler, the company achieved a 100% early and accurate detection of product pH probe issues, preventing the waste of $5 million USD in biopharma drug substance.
Read the full details in this case study.
Related Content
Process industries like bulk chemicals, specialty chemicals and pharmaceuticals strive to optimize production processes with existing resources and data to remain competitive and profitable. By implementing product and process quality analytics solutions like Aspen ProMV® and Aspen Process Pulse™, manufacturers can achieve operational and financial benefits while also improving fouling, product yield and overall plant efficiency. Watch this video to find out how leading chemical and pharmaceutical companies have saved up to 25% in costs and increased yield by up to 2%.
Case Study:
Ferring Prototypes Continuous Manufacturing with Advanced PAT and Closed-Loop Control, Potential for Dramatically Lower COGS
Case Study:
GlaxoSmithKline Speeds Up Batch Release Time: A Study in Digital Transformation
White Paper:
Solution Brief: Accelerate Market Growth with New Advances in Process Analytical Technology